SG Americas Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-169,600
Closed -$157K 3567
2019
Q3
$157K Buy
169,600
+60,000
+55% +$5.7M ﹤0.01% 2485
2019
Q2
$243K Sell
109,600
-228,200
-68% -$21.7M ﹤0.01% 2306
2019
Q1
$415K Sell
337,800
-313,000
-48% -$27.4M ﹤0.01% 1990
2018
Q4
$10.1M Buy
650,800
+147,300
+29% +$10.9M 0.09% 200
2018
Q3
$4.39M Sell
503,500
-119,600
-19% -$10.6M 0.03% 585
2018
Q2
$9.09M Sell
623,100
-1,239,900
-67% -$103M 0.08% 245
2018
Q1
$11M Buy
1,863,000
+1,235,600
+197% +$119M 0.09% 183
2017
Q4
$4.01M Buy
627,400
+114,600
+22% +$12.9M 0.04% 479
2017
Q3
$655K Buy
512,800
+77,000
+18% +$10.5M 0.01% 1596
2017
Q2
$610K Sell
435,800
-25,900
-6% -$3.17M 0.01% 1735
2017
Q1
$782K Buy
461,700
+74,000
+19% +$8.86M 0.01% 1541
2016
Q4
$716K Buy
387,700
+99,300
+34% +$11.1M 0.01% 1497
2016
Q3
$1.01M Buy
288,400
+31,900
+12% +$3.45M 0.01% 1164
2016
Q2
$1.92M Sell
256,500
-231,000
-47% -$23.9M 0.01% 866
2016
Q1
$3.11M Sell
487,500
-200,400
-29% -$20.6M 0.02% 610
2015
Q4
$1.63M Buy
+687,900
New +$79.6M 0.01% 840
2015
Q3
Sell
-281,500
Closed -$1.3M 3084
2015
Q2
$1.3M Sell
281,500
-1,239,800
-81% -$142M 0.01% 936
2015
Q1
$15M Buy
1,521,300
+1,338,100
+730% +$160M 0.09% 172
2014
Q4
$5K Hold
183,200
﹤0.01% 3123
2014
Q3
$63K Buy
+183,200
New +$16.5M ﹤0.01% 2457
2014
Q1
Sell
-223,600
Closed -$14K 3062
2013
Q4
$14K Buy
223,600
+4,600
+2% +$364K ﹤0.01% 2536
2013
Q3
$142K Buy
219,000
+76,200
+53% +$5.34M ﹤0.01% 2424
2013
Q2
$447K Buy
+142,800
New +$8.59M ﹤0.01% 1314

Other funds holding CELG

SG Americas Securities's CELG Position: Q4 2019 in Review

SG Americas Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 60,558 shares — an estimated $6.01M sold.

SG Americas Securities first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $221M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SG Americas Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SG Americas Securities sold 60,558 Celgene Corp shares in Q4 2019, an estimated $6.01M.
  • SG Americas Securities first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • SG Americas Securities's Celgene Corp position peaked at $221M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SG Americas Securities's 13F filing for Q4 2019, filed 28 Jan 2020.